917. Antimicrobial Stewardship in the Emergency Department
Session: Symposium: Stewardship in Challenging Populations
Friday, October 5, 2018: 9:35 AM
Room: S 206-208
Larissa May, MD, MSPH, Emergency Medicine, University of California-Davis, Sacramento, CA

Dr. Larissa May is Professor of Emergency Medicine and Director of Emergency Department and Outpatient Antibiotic Stewardship for the University of California-Davis Health System. She is a national expert in antibiotic stewardship in the emergency department (ED). Dr. May received her M.D., her MSPH in Public Health Microbiology and Emerging Infectious Diseases, and her MSHS in Clinical and Translational Research from The George Washington University. Dr. May’s research interests center on clinical infectious disease epidemiology and management, with a particular focus on the application of rapid molecular diagnostic assays, behavioral economics and clinical guidelines to improve antibiotic stewardship in the ED. Dr. May has served as an investigator on multiple federally-funded and industry-funded trials evaluating antimicrobial stewardship strategies in the ED. She has published over 60 peer-reviewed articles in her field. She has also served on numerous committees and task forces focused on antibiotic stewardship, emergency preparedness, and infectious diseases surveillance for the Centers for Disease Control and Prevention and professional organizations including the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America and co-leads the California Department of Public Health Emergency Department Antibiotic Stewardship Collaborative.


L. May, Roche: Grant Investigator and Scientific Advisor , Consulting fee and Research grant . Cepheid: Grant Investigator and Speaker's Bureau , Research grant and Speaker honorarium . BioFire: Consultant , Consulting fee . Qvella: Scientific Advisor , Speaker honorarium .

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.